206
J. Wolf et al. / Journal of Molecular Catalysis A: Chemical 259 (2006) 205–212
1H data were recorded on Bruker AC200, AM-250 and AV-
1H, N–CH–N), 7.97 (t, J = 1.5 Hz, 1H, MesN–CH C), 7.16 (t,
J = 1.5 Hz, 1H, AlkN–CH C), 6.99 (s, 2H, CH (Mes)), 4.85
(t, J = 4.9 Hz, 2H, N–CH2), 4.03 (t, J = 4.8 Hz, 2H, CH2–O),
3.54 (br, 1H, OH), 2.33 (s, 3H, p-CH3), 2.21 (q, J = 5.7 Hz, 2H,
C–CH2–C), 2.07 (s, 6H, o-CH3). MS [DCI(NH3)] m/z, (%):
245.2, (100) [C15H21N2O+]; 79.2, (100) [Br−].
500 spectrometers, operating at 200, 250 and 500 MHz, respec-
tively. 13C{H, P} and 31P{H} NMR data were recorded on the
Bruker AV-500 instrument, operating at 125.8 and 202.5 Hz,
respectively. The spectra were referenced internally using the
signal from the residual protiosolvent (1H) or the solvent sig-
nals (13C), and externally using 85% H3PO4 for 31P. Mass
spectra were obtained from acetonitrile or methanol solutions
on a TSQ7000 instrument from ThermoElectron (electrospray
ionisation or chemical ionisation), and from DMSO or DMF
solutions on a Nermag R10-10 instrument (FAB). GC chro-
matograms were recorded on a Fisons 8000 Series GC equipped
with a SPB-5 capillary column and the products were identi-
icals were from Acros, Aldrich, Alfa Aesar, Avocado or Fluka
and used as received. N-(2,4,6-trimethylphenyl)imidazole (2a)
and N-(2,6diisopropylphenyl)imidazole (2b) were prepared as
described by Arduengo et al. [20] and Johnson [21]. Compound
1a was synthesised as previously described [19].
2.2.3. 1-(2-Bromoethyl)-3-(2,6-diisopropylphenyl)
imidazolium bromide (4b)
PBr3 (0.83 mL, 8.80 mmol) was slowly added to a cold
CH2Cl2 solution (70 mL, 0 ◦C) of 3b (2.59 g, 7.33 mmol). The
mixture was stirred for 20 h at room temperature, diluted with
CH2Cl2 (70 mL) and added to a cold, saturated aq. NaHCO3
solution (35 mL, 0 ◦C). The organic phase was extracted and
washed with a cold, saturated aq. NaHCO3 solution (1 × 10 mL,
0 ◦C). Subsequently, it was dried (MgSO4), filtered and the sol-
vent was removed in vacuo to give a white solid. Yield: 2.38 g
1
(78%). H NMR (δ, 500 MHz, CDCl3): 10.07 (t, J = 1.6 Hz,
1H, N–CH–N), 8.67 (t, J = 1.6 Hz, 1H, (DIP)N–CH C), 7.44
(t, J = 7.9 Hz, 1H, p-CH (DIP)), 7.20 (d, J = 7.9 Hz, 2H, m-
CH (DIP)), 7.13 (t, J = 1.6 Hz, 1H, AlkN–CH C), 5.15 (t,
J = 5.4 Hz, 2H, N–CH2), 3.96 (t, J = 5.4 Hz, 2H, CH2–Br),
2.23 (h, J = 6.8 Hz, 2H, CH–(CH3)2), 1.09 (d, J = 6.8 Hz,
2.2. Synthesis of ligands
2.2.1. 1-(2-Hydroxyethyl)-3-(2,6-diisopropylphenyl)-
imidazolium bromide (3b)
12H, CH–(CH3)2), 1.05 (d, J = 6.8 Hz, 12H, CH–(CH3)2); 13
C
NMR (δ, 125.8 MHz, CDCl3): 145.35 (o-C (DIP)), 138.21
(N–CH–N), 131.85 (p-CH (DIP)), 129.98 (N–C (DIP)), 124.57
(m-CH (DIP)), 124.39 ((DIP)N–CH ), 123.94 (AlkN–CH ),
50.73 (CH2–N), 32.00 (CH2–Br), 28.50 (CH–(CH3)2), 24.47
(CH–(CH3)2), 24.00 (CH–(CH3)2). m.p. 73–75 ◦C. Anal. calcd.
for C17H24Br2N2; C: 49.06, H: 5.81, N: 6.73%; found: C:
48.71, H: 6.11, N: 6.43%. MS (ESI) m/z, (%): 335, (100)
[C17H24BrN2+]; 79, (100) [Br−].
2-Bromoethanol (2.5 mL, 35 mmol) was added to a toluene
solution (150 mL) of 2b (6.2 g, 27.2 mmol). The mixture was
stirred at 120 ◦C for 20 h. During this time a yellow-orange
oil separated out in the flask. The mixture was cooled to
room temperature and the toluene phase was removed. The
oil was extracted with CH2Cl2 (20 mL), the resulting solution
was slowly precipitated in ether (400 mL), and the pale yel-
low solid which formed was filtered and dried in vacuo. Yield:
6.83 g (72%). 1H NMR (δ, 500 MHz, CDCl3): 9.50 (s, 1H,
N–CH–N), 8.19 (s, 1H, (DIP)N–CH C), 7.38 (t, J = 7.9 Hz, 1H,
p-CH (DIP)), 7.15 (d, J = 7.9 Hz, 2H, m-CH (DIP)), 7.09 (s,
1H, AlkN–CH C), 4.73 (t, J = 4.8 Hz, 2H, N–CH2), 3.96 (br,
1H, OH), 3.84 (t, J = 4.8 Hz, 2H, CH2–OH), 2.15 (h, J = 6.8 Hz,
2H, CH–(CH3)2), 1.01 (d of d, J = 6.8 Hz, 12H, CH–(CH3)2);
13C NMR (δ, 125.8 MHz, CDCl3): 145.35 (o-C (DIP)), 137.63
(N–CH–N), 131.75 (p-CH (DIP)), 130.00 (N–C (DIP)), 124.50
(m-CH (DIP)), 124.31 ((DIP)N–CH ), 123.73 (AlkN–CH ),
60.17 (CH2–OH), 52.01 (CH2–N), 28.43 (CH–(CH3)2), 24.33
(CH–(CH3)2), 24.00 (CH–(CH3)2). m.p. 169–170 ◦C. Anal.
calcd. for C17H25BrN2O; C: 57.79, H: 7.13, N: 7.93%; found:
C: 57.54, H: 6.90, N: 7.79%. MS (ESI) m/z, (%): 273.15, (100)
[C17H25N2O+]; 79, (100) [Br−].
2.2.4. 1-(3-Bromo-n-propyl)-3-(2,4,6-trimethylphenyl)
imidazolium bromide (4c)
PBr3 (1.1 mL, 11.5 mmol)wasslowlyaddedtoacoldCH2Cl2
solution (80 mL, 0 ◦C) of 3c (3.26 g, 10 mmol). The mixture
was stirred for 15 h at room temperature, diluted with CH2Cl2
(80 mL) and added to a cold, saturated aq. NaHCO3 solution
(25 mL, 0 ◦C). The organic phase was extracted and washed
with cold, saturated aq. NaHCO3 (1 × 10 mL, 0 ◦C). Subse-
quently, it was dried (MgSO4), filtered and the solvent was
removed in vacuo to give a pale yellow solid. Yield: 3.37 g
(87%). 1H NMR (δ, 500 MHz, CDCl3): 10.23 (s, 1H, N–CH–N),
8.23 (s, 1H, MesN–CH C), 7.23 (s, 1H, AlkN–CH C), 6.95
(s, 2H, CH (Mes)), 4.86 (t, J = 6.8 Hz, 2H, N–CH2), 3.48 (t,
J = 6.3 Hz, 2H, CH2–Br), 2.63 (q, J = 5.2 Hz, 2H, C–CH2–C),
2.29 (s, 3H, p-CH3), 2.02 (s, 6H, o-CH3); 13C NMR (δ,
125.8 MHz, CDCl3): 141.28 (p-C (Mes)), 137.78 (N–CH–N),
134.10 (o-C (Mes)), 130.62 (N–C (Mes)), 129.85 (CH (Mes)),
124.04 (AlkN–CH ), 123.39 (MesN–CH ), 48.79 (N–CH2),
33.01 (C–CH2–C), 29.13 (CH2–Br), 21.11 (p-CH3), 17.72 (o-
CH3). m.p. 148–149 ◦C. Anal. calcd. for C15H20Br2N2; C:
46.42, H: 5.19, N: 7.22%; found: C: 46.30, H: 4.92, N: 7.11%.
MS (ESI) m/z, (%): 399, (100) [C15H20BrN2+]; 79–81, (100)
[Br−].
2.2.2. 1-(3-Hydroxy-n-propyl)-3-(2,4,6-trimethylphenyl)
imidazolium bromide (3c)
3-Bromo-1-propanol (2.2 mL, 24.0 mmol) was added to a
toluene solution (60 mL) of 2a (3.72 g, 20.0 mmol). The mix-
ture was stirred at 120 ◦C for 15 h. During this time a cream
solid precipitated in the flask. The suspension was cooled to
room temperature, the solid was decanted, washed with toluene
(2 × 15 mL) and dried in vacuo. A white solid was obtained.
1
Yield: 4.47 g (69%). H NMR (δ, 250 MHz, CDCl3): 9.64 (s,